⌕
Immunocore Holdings · IMCR · Nasdaq
Tenet 53 · Mixed
Compare
$27.81−3.71%At closeTenet 53 · Mixed
$27.81−1.07 (−3.71%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Immunocore Holdings (IMCR) Stock

Immunocore Holdings (IMCR) closed at $27.81 on Nov 17, 2026; its Tenet Score is 53 of 100 against 340 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

19 figures withheld by our checks. Each blank figure names its reason.

Key stats

Close
$27.81
Nov 17, 2026
Market cap
$1.5B
share price × the latest quarter's diluted weighted-average share count (vendor)
52-week range
27.50 – 40.71
low → high · as of close, Nov 16, 2026
Tenet Score
53/100
Mixed · 340 Healthcare peers

Industry: Drugs

Immunocore Holdings plc scores 53/100. Mixed. A balanced profile across the four pillars versus 340 Healthcare peers.

Tenet Score · vs sector

n=340
53/ 100
Mixed
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
58
Quality
49
Health
49
Growth
58

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueCQualityDHealthDGrowthCMomentumF
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/E
—
Not meaningful: the company made a loss.
P/B
3.6×
Sep 30, 2026 balance sheet
P/S
3.5×
price to sales, TTM through Sep 30, 2026 · as of close, Nov 16, 2026
ROE
−8%
TTM through Sep 30, 2026
Operating margin
−11.3%
fiscal 2025, before interest and tax
Net margin
−7.5%
TTM through Sep 30, 2026
Current ratio
4.62
Sep 30, 2026 balance sheet
Net debt / EBITDA
—
Not meaningful: EBITDA is zero or negative.
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file

The whole report, at a glance · every card is a live peek, click any to open the section

About Immunocore Holdings plc

Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or…

Composite computed Nov 16, 2026 · peer basis: Healthcare (n=340) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 12 US ETFs · top wrappers by weightSee all ETFs holding IMCR →

Similar-sized companies in Drugs

The 10 companies in this industry closest in market cap, as of Nov 16, 2026.

What sector and industry is Immunocore Holdings in?

Immunocore Holdings is in the Healthcare sector and the Drugs industry.

What is Immunocore Holdings' Tenet Score?

Immunocore Holdings' Tenet Score is 53 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.